摘要:
1,5-Benzodiazepine derivatives represented by general formula (1) and drugs containing the same, wherein R 1 represents lower alkyl; R 2 and R 3 are the same or different and each represents hydrogen or lower alkyl; R 4 represents cyclohexyl or phenyl; and n is an integer of 1 to 3. These compounds are useful as remedies/preventives for diseases in which gastrin receptor and/or CCK-B receptor participate.
摘要翻译:由通式(1)表示的1,5-苯并二氮杂衍生物和含有该化合物的药物,其中R 1表示低级烷基; R 2和R 3相同或不同,各自表示氢或低级烷基; R 4表示环己基或苯基; 并且n为1〜3的整数。这些化合物可用作胃泌素受体和/或CCK-B受体参与的疾病的补救措施/预防剂。
摘要:
The present invention relates to remedies for AIDS, which comprises as active ingredients (a) a composition containing as the primary component a polysaccharide derived from a hot water extract of human-type tubercle bacillus and (b) a nucleoside-type anti-HIV agent. Due to the incorporation of composition (a), the present invention enhances the therapeutic effect of nucleoside-type anti-HIV agents on AIDS.
摘要:
The present invention is directed to 3-benzoylindole derivatives represented by the following formula (I): (wherein R 1 represents a lower alkyl group, n is an integer from 1 to 5; each of R 2 and R 3 represents a hydrogen atom, a lower alkyl group, or an optionally substituted phenyl group; and R 4 represents a hydrogen atom, a lower alkyl group, or a benzyl group) and to a pharmaceutical containing the same. This compound is endowed with strong α 1 -adrenergic receptor blocking action and strong testosterone 5α-reductase inhibitory action, as well as high level of safety, and thus is useful as an excellent preventive or therapeutic drug for prostatic hypertrophy or accompanying urination disorder, alopecia, and acne.
摘要翻译:本发明涉及由下式(I)表示的3-苯并吲哚衍生物:其中R 1表示低级烷基,n为1〜5的整数,R 2和 R 3表示氢原子,低级烷基或任选取代的苯基; R 4表示氢原子,低级烷基或苄基)和含有该烷基的药物。 该化合物具有强α1-肾上腺素能受体阻断作用和强烈的睾酮5α-还原酶抑制作用,并具有高水平的安全性,因此可用作前列腺肥大或伴随排尿障碍的优良预防或治疗药物, 秃发和痤疮。
摘要:
An indan derivative represented by general formula (1) or a pharmacologically acceptable salt thereof, wherein R1 represents C¿1? to C12 alkyl, benzyl, styryl, naphthyl, optionally substituted phenyl or optionally substituted thienyl; R?2¿ represent carboxyl, C¿1? to C4 alkoxycarbonyl (2), or (3); Y represents -(CH2)p - (wherein p represents an integer of 0 to 5), -CO-(CH2)q∩ or CH(OH)-(CH2)q∩ (wherein q represents an integer of 1 to 4, and symbol ∩ represents a linkage to R?2¿), oxymethylene or ethylene; and n represents an integer of 1 to 4. This compound antagonizes the action of thromboxane A¿2? so potently that it can be utilized to treat or prevent diseases caused by thromboxane A2, such as angiosis, vascular twitch or asthma.
摘要:
An indan derivative represented by general formula (1) or a pharmacologically acceptable salt thereof, wherein R1 represents C¿1? to C12 alkyl, benzyl, styryl, naphthyl, optionally substituted phenyl or optionally substituted thienyl; R?2¿ represent carboxyl, C¿1? to C4 alkoxycarbonyl (2), or (3); Y represents -(CH2)p - (wherein p represents an integer of 0 to 5), -CO-(CH2)q∩ or CH(OH)-(CH2)q∩ (wherein q represents an integer of 1 to 4, and symbol ∩ represents a linkage to R?2¿), oxymethylene or ethylene; and n represents an integer of 1 to 4. This compound antagonizes the action of thromboxane A¿2? so potently that it can be utilized to treat or prevent diseases caused by thromboxane A2, such as angiosis, vascular twitch or asthma.
摘要:
The invention relates to indoleacetic acid derivatives represented by general formula (I), [wherein X represents a piperidino group, a 1-pyrrolidinyl group or a 3-hydroxy-1-pyrrolidinyl group, Y represents α, (wherein R1 represents a hydrogen atom or a lower alkyl group, and $(1,3)$ represents 0, 1 or 2) or β, (wherein R2 represents a hydrogen atom, a lower akyl group or a hydroxy group, m represents 0, 1 or 2, and n represents 1, 2 or 3)] and their salts, and antiinflammatory agents, antirheumatic agents and antiulcer agents containing them as active ingredients. The compounds possess a strong antiinflammatory action while causing extremely reduced troubles of digestive organs which is a serious defect with conventional non-steroidal antiinflammatory agents, and possess an excellent antiulcer action as well.
摘要:
This invention relates to substituted acetamide derivatives represented by general formula (I), salts thereof, cyclodextrin inclusion compounds thereof, and an antiulcer drug containing same as an active ingredient, wherein Y represents a piperidino group, a 1-pyrrolidinyl group or a 3-hydroxy-1-pyrrolidinyl group, and Z represents a group selected from among groups (a) to (e): (a) cyano group, (b), (c), (d) and (e). The compounds (I) possess an excellent antiulcer activity and a high safty, and hence an antiulcer drug containing same is useful as a drug for prophylaxis and treatment of acute or chronic gastric ulcer, duodenal ulcer, gastritis and hyperacidity.
摘要:
Novel condensed benzene derivatives having prolyl endopeptidase inhibitory, anti-hypoxic, and anti-amnesic activities are disclosed. The compounds are represented by the following (I), wherein A represents a methylene, ethylene, or propylene group, B represents a methylene or ethylene group, m denotes an integer of 0-5, X and Y, which may be same or different, individually represent a methylene group or sulfur atom, R¹ represents a hydrogen atom, a carboxyl, lower alkyloxycarbonyl, hydroxymethyl, or formyl group, R² represents a hydrogen atom, a halogen atom, a lower alkyl, lower alkoxy, nitro, or amino group, R³ represents a hydrogen atom or a lower alkyl group, and the dotted line may optionally be present. They are useful as a medicine for treating or preventing cerebral circulation disorder, cerebral metabolism disorder, or memory disturbance.
摘要:
A parmaceutical composition comprising: a 1:1 solvate of 5-(5,5-dimethyl-1,3,2-dioxaphosphorinane-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridine carboxylic acid 2-(phenyl(phenylmethyl)amino) ethyl ester P-oxide hydrochloride-ethanol (NZ-105) and hydroxypropylmethylcellulose acetate succinate is disclosed. The composition can easily be prepared into tablets, capsules, granules, and powders, which exhibit an enhanced bioavailability, e.g. provides a high blood concentration of the active component NZ-105 and ensures a high total drug absorption.